S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20

Titan Medical Stock Forecast, Price & News

-0.01 (-1.41%)
(As of 11/26/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
467,837 shs
Average Volume
1.67 million shs
Market Capitalization
$77.93 million
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive TMDI News and Ratings via Email

Sign-up to receive the latest news and ratings for Titan Medical and its competitors with MarketBeat's FREE daily newsletter.

Titan Medical logo

About Titan Medical

Titan Medical, Inc. engages in the research and development of a computer-assisted robotic surgical technology for application in minimally invasive surgery (MIS). Its portfolio, the Enos™ system, is a robotic single access surgery with dual 3D and 2D definition vision systems, multi-articulating instruments, and a surgeon workstation. The company was founded on July 28, 2008 and is headquartered in Toronto, Canada.


See More Headlines

Industry, Sector and Symbol

Surgical & medical instruments
Current Symbol
Year Founded

Sales & Book Value

Annual Sales
$20 million
Book Value
($0.17) per share


Net Income
$-24.18 million
Pretax Margin




Free Float
Market Cap
$77.93 million
Not Optionable

Company Calendar

Last Earnings
Fiscal Year End
Next Earnings (Estimated)


Overall MarketRank

1.58 out of 5 stars

Medical Sector

1037th out of 1,391 stocks

Surgical & Medical Instruments Industry

105th out of 125 stocks

Analyst Opinion: 3.5Community Rank: 4.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Titan Medical (NASDAQ:TMDI) Frequently Asked Questions

Is Titan Medical a buy right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Titan Medical in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Titan Medical stock.
View analyst ratings for Titan Medical
or view top-rated stocks.

How has Titan Medical's stock price been impacted by Coronavirus (COVID-19)?

Titan Medical's stock was trading at $0.20 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, TMDI stock has increased by 250.7% and is now trading at $0.7013.
View which stocks have been most impacted by COVID-19

Are investors shorting Titan Medical?

Titan Medical saw a decrease in short interest during the month of November. As of November 15th, there was short interest totaling 712,600 shares, a decrease of 26.3% from the October 31st total of 967,300 shares. Based on an average trading volume of 626,700 shares, the short-interest ratio is presently 1.1 days.
View Titan Medical's Short Interest

When is Titan Medical's next earnings date?

Titan Medical is scheduled to release its next quarterly earnings announcement on Monday, February 28th 2022.
View our earnings forecast for Titan Medical

How were Titan Medical's earnings last quarter?

Titan Medical Inc. (NASDAQ:TMDI) announced its earnings results on Thursday, November, 11th. The company reported ($0.08) EPS for the quarter, missing the Thomson Reuters' consensus estimate of ($0.06) by $0.02. During the same period in the previous year, the firm posted ($0.02) EPS.
View Titan Medical's earnings history

What price target have analysts set for TMDI?

2 brokers have issued 12 month price targets for Titan Medical's shares. Their forecasts range from $4.00 to $4.00. On average, they anticipate Titan Medical's stock price to reach $4.00 in the next year. This suggests a possible upside of 470.4% from the stock's current price.
View analysts' price targets for Titan Medical
or view top-rated stocks among Wall Street analysts.

Who are Titan Medical's key executives?

Titan Medical's management team includes the following people:
  • David J. McNally, President, Chief Executive Officer & Director
  • Stephen L. Lemieux, Chief Financial Officer
  • Perry A. Genova, Senior Vice President-Research & Development
  • Deepak Basra, Vice President-Strategy & Business Development
  • Chris Seibert, Vice President-Business Development

What other stocks do shareholders of Titan Medical own?

What is Titan Medical's stock symbol?

Titan Medical trades on the NASDAQ under the ticker symbol "TMDI."

Who are Titan Medical's major shareholders?

Titan Medical's stock is owned by a number of retail and institutional investors. Top institutional investors include Masters Capital Management LLC (1.35%), Essex LLC (1.34%), Morgan Stanley (0.16%), Two Sigma Advisers LP (0.08%), UBS Group AG (0.04%) and Reilly Financial Advisors LLC (0.03%).

Which institutional investors are selling Titan Medical stock?

TMDI stock was sold by a variety of institutional investors in the last quarter, including Two Sigma Advisers LP, and Morgan Stanley.

Which institutional investors are buying Titan Medical stock?

TMDI stock was acquired by a variety of institutional investors in the last quarter, including Essex LLC, Masters Capital Management LLC, Reilly Financial Advisors LLC, UBS Group AG, and Strong Tower Advisory Services.

How do I buy shares of Titan Medical?

Shares of TMDI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Titan Medical's stock price today?

One share of TMDI stock can currently be purchased for approximately $0.70.

How much money does Titan Medical make?

Titan Medical has a market capitalization of $77.93 million and generates $20 million in revenue each year. The company earns $-24.18 million in net income (profit) each year or ($0.49) on an earnings per share basis.

How many employees does Titan Medical have?

Titan Medical employs 9 workers across the globe.

What is Titan Medical's official website?

The official website for Titan Medical is www.titanmedicalinc.com.

Where are Titan Medical's headquarters?

Titan Medical is headquartered at 155 UNIVERSITY AVENUE, TORONTO A6, M5H 3B7.

How can I contact Titan Medical?

Titan Medical's mailing address is 155 UNIVERSITY AVENUE, TORONTO A6, M5H 3B7. The company can be reached via phone at (416) 548-7522.

This page was last updated on 11/28/2021 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.